GRAND RAPIDS, Mich., June 11, 2025 — cultivate(MD), a prominent firm, is happy to share that Instrumentum, LLC, a rapidly expanding leader in surgical instrument sterilization services, has acquired its portfolio company, Sterile Processing Express (SPDx).

This calculated acquisition broadens Instrumentum’s operational reach to five locations spanning four states, greatly improving its ability to handle the rising need for offsite sterile processing. This demand is fueled by the ongoing increase in elective surgeries performed at hospitals, clinics, and ambulatory surgery centers (ASCs).

“SPDX is extremely excited about this partnership and merger with Instrumentum,” stated David Blue, Director at cultivate(MD) and SPDx Board Member. “We identified the significant value proposition for both ASCs and Hospitals early on, and we were confident that this bold idea would be successfully executed. We anticipate great things ahead!”

The transaction signifies a positive outcome for SPDx’s sterile processing model, which validates cultivate(MD)’s original investment strategy. As part of Instrumentum, SPDx’s operational strengths will be integrated with a scalable commercial platform, supporting nationwide growth and enhancing value within the surgical care industry.

“This transaction is a strategic move that combines SPDx’s facility launch expertise, quality standards, and operational capabilities with Instrumentum’s commercial strategy. This ensures that the combined efforts of both teams will maximize the potential of this market opportunity,” stated Matt Ahearn, Director at cultivate(MD) and SPDx Chairman of the Board. “We are confident that this asset sale will create lasting value for everyone involved.” Mr. Ahearn will remain on the Board of Instrumentum as an Observer.

This event is a major achievement for cultivate(MD), demonstrating its commitment to finding and supporting innovative healthcare solutions that produce significant returns and meaningful clinical results.

About cultivate(MD)

cultivate(MD) is a firm focused on promoting healthcare innovation. With a strong emphasis on state-of-the-art medical technologies, cultivate(MD) supports companies that demonstrate the potential to transform healthcare delivery and patient care.

For more information, visit: 

About Instrumentum

Instrumentum is a rising leader in surgical instrument sterilization, serving outpatient surgery centers and hospitals. Instrumentum aims to be the most reliable provider of medical device sterilization services. By providing superior sterile processing, they enable surgeons and staff to operate confidently at their full capacity. Headquartered with its first facility in the Research Park at Florida Atlantic University in Boca Raton, FL, Instrumentum also has facilities operating in Chicago, Phoenix, Long Beach and Modesto. They are currently selecting sites for six new locations planned for 2026.

For more information, visit .

Cautionary Note Regarding Forward-Looking Statements

This communication includes “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements involve plans, beliefs, expectations, assumptions, and other statements that are not strictly historical facts. Readers should be aware that these forward-looking statements are predictions and involve risks and uncertainties. Furthermore, these statements are relevant only as of the date they are made, and we do not intend to update or revise them. This communication also contains market data regarding our business and industry, including projections based on assumptions we consider reasonable and significant as of this date. Should any of these assumptions prove incorrect, actual results may differ significantly from the projections.

SOURCE cultivate(MD)

“`